Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Joseph Cofrancesco"'
Autor:
Chunfa C. Jie, Tanya M. Teslovich, C. Conover Talbot, Ahmad R. Sedaghat, Jennifer R. German, Robert F. Siliciano, Joseph Cofrancesco
Publikováno v:
Journal of Virology. 82:1870-1883
Human immunodeficiency virus type 1 (HIV-1) is the etiologic agent of AIDS, which is a manifestation of the progressive CD4+ T-cell depletion that occurs in the setting of HIV-1 infection (19, 59). During acute infection by HIV-1, the process of CD4+
Autor:
Timothy P. Brennan, Yi Liu, Christine M. Haggerty, Patricia K. Lee, Thomas C. Quinn, Joel E. Gallant, Ashrit R. Kamireddi, Deborah Persaud, Tara L. Kieffer, Janet D. Siliciano, Jessica Lee, Justin R. Bailey, Robert F. Siliciano, Joseph Cofrancesco, Claus O. Wilke, Stuart C. Ray, Ahmad R. Sedaghat, Richard E. Nettles, Megan Wind-Rotolo
Publikováno v:
Journal of Virology. 80:6441-6457
Antiretroviral therapy can reduce human immunodeficiency virus type 1 (HIV-1) viremia to below the detection limit of ultrasensitive clinical assays (50 copies of HIV-1 RNA/ml). However, latent HIV-1 persists in resting CD4 + T cells, and low residua
Autor:
Cecily Alcock, Joseph Cofrancesco, Paul A. Pham, Daphne Monie, Janet D. Siliciano, Haili Zhang, Quan Li, Robert F. Siliciano, Deborah Persaud, Tara Kiefer, Yan Zhou
Publikováno v:
Journal of Virology. 78:1718-1729
Human immunodeficiency virus type 1 (HIV-1)-infected individuals who develop drug-resistant virus during antiretroviral therapy may derive benefit from continued treatment for two reasons. First, drug-resistant viruses can retain partial susceptibili